All Companies

MRK

Merck & Co., Inc.

Pharmaceutical Preparations

$146.87updated Sep 19, 2026

Congressional trading profile for Merck & Co., Inc. (MRK), covering 41 disclosed transactions by 18 lawmakers.

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Total Trades

41

Politicians Trading

18

Last Traded

Aug 24, 2026

Price history

Congressional Trades

PoliticianNotifiedTradedTypeAmountChange
Julie JohnsonDJan 15, 2026Dec 18, 2025Sell$1,001 - $15,000+45.86%
Julie JohnsonDDec 11, 2025Nov 13, 2025Sell$1,001 - $15,000+58.04%
Val T. HoyleDOct 10, 2025Sep 23, 2025Sell$1,001 - $15,000+83.68%
Julie JohnsonDSep 11, 2025Aug 14, 2025Sell$1,001 - $15,000+77.46%
Ritchie TorresDAug 20, 2025Jul 11, 2025Sell$1,001 - $15,000+76.19%
Gilbert Ray Cisneros, Jr.DJun 6, 2025May 30, 2025Sell$1,001 - $15,000+91.14%
Kelly MorrisonDApr 11, 2025Mar 20, 2025Sell$1,001 - $15,000+55.04%
Gilbert Ray Cisneros, Jr.DApr 7, 2025Mar 31, 2025Sell$15,001 - $50,000+63.63%
Gilbert Ray Cisneros, Jr.DFeb 11, 2025Jan 24, 2025Sell$1,001 - $15,000+53.71%
Josh GottheimerDFeb 10, 2025Jan 27, 2025Sell$15,001 - $50,000+49.96%
Jared MoskowitzDFeb 10, 2025Jan 15, 2025Sell$1,001 - $15,000+46.74%
Jared MoskowitzDFeb 10, 2025Jan 15, 2025Sell$1,001 - $15,000+46.74%